NCT03700385: A trial that was reported late by Boston Scientific Corporation
This trial has reported, although it was 238 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03700385 |
|---|---|
| Title | The IMPULSE Study: A Safety and Feasibility Study of the IOWA Approach Endocardial Ablation System to Treat Atrial Fibrillation |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 19, 2018 |
| Completion date | Dec. 21, 2018 |
| Required reporting date | Dec. 21, 2019, midnight |
| Actual reporting date | Aug. 15, 2020 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 238 |